Novogene Co., Ltd. Sustainability Profile
Novogene Co., Ltd., a leading global provider of genomic services, is headquartered in China (CN) and operates extensively across North America, Europe, and Asia. Founded in 2011, Novogene has rapidly established itself in the biotechnology industry, specialising in next-generation sequencing (NGS) and bioinformatics solutions. The company offers a comprehensive range of services, including whole genome sequencing, targeted sequencing, and RNA sequencing, distinguished by its high throughput and accuracy. Novogene's commitment to innovation has led to significant advancements in genomic research, positioning it as a trusted partner for academic institutions, pharmaceutical companies, and healthcare providers. With a strong market presence and numerous accolades, Novogene continues to drive progress in genomics, making substantial contributions to personalised medicine and agricultural biotechnology.
DitchCarbon Score
How does Novogene Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novogene Co., Ltd.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novogene Co., Ltd.'s reported carbon emissions
Novogene Co., Ltd., headquartered in China, is committed to addressing climate change through various initiatives. While specific emissions data for the most recent year is not available, the company has made significant commitments towards reducing its carbon footprint. Novogene is committed to achieving net-zero emissions, as indicated by its near-term target status of "Committed" under the Science Based Targets initiative (SBTi). The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector and has set a commitment to align its operations with climate action goals. Although no specific reduction targets or absolute emissions figures are provided, Novogene's commitment to net-zero emissions reflects a proactive approach to sustainability and climate responsibility. As of now, Novogene does not inherit emissions data from any parent or related organizations, indicating that its climate commitments are independently established. The absence of specific emissions data highlights the need for ongoing transparency and reporting in line with industry standards.
How Carbon Intensive is Novogene Co., Ltd.'s Industry?
How Carbon Intensive is Novogene Co., Ltd.'s Location?
Novogene Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Novogene Co., Ltd. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
